Haim Werner, Ernst-A.Chantelau: Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years. In: Diabetology & Metabolic Syndrome. Vol. 3, Nr.13, 2011 (biomedcentral.com [abgerufen am 29. Juli 2020]).
Kasia J. Lipska: Insulin Analogues for Type 2 Diabetes. In: JAMA. Band321, Nr.4, 2019, S.350–351, doi:10.1001/jama.2018.21356.
Kristin Eckardt, Jürgen Eckel: Insulin analogues: Action profiles beyond glycaemic control. In: Archives of Physiology and Biochemistry. Band114, Nr.1, 2008, S.45–53, doi:10.1080/13813450801983369.
frontiersin.org
Laura Sciacca, Rosario Le Moli and Riccardo Vigneri: Insulin analogs and cancer. In: Front. Endocrinol. 10. Februar 2012, abgerufen am 29. Juli 2020.
tau.ac.il
werner.tau.ac.il
Haim Werner, Doron Weinstein, Einat Yehezkel, Zvi Laron: Controversies in the use of insulin analogues. In: Expert.Opin.Biol.Ther. Band11, Nr.2, 2011, S.199–209 (tau.ac.il [PDF; abgerufen am 29. Juli 2020]).